Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  AcelRx Pharmaceuticals Inc    ACRX

ACELRX PHARMACEUTICALS INC

(ACRX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

ACELRX PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:35pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.





On January 8, 2019, John Saia, General Counsel of AcelRx Pharmaceuticals, Inc. (the "Company"), notified the Company of his resignation from all positions with the Company effective immediately.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACELRX PHARMACEUTICALS INC
06/03ACELRX PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termina..
AQ
06/03ACELRX PHARMACEUTICALS : announces the closing of a $25 million senior secured d..
PR
05/09ACELRX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
05/08ACELRX PHARMACEUTICALS : 1Q Earnings Snapshot
AQ
05/08ACELRX PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fina..
AQ
05/08ACELRX PHARMACEUTICALS : Reports First Quarter 2019 Financial Results
PR
04/25ACELRX PHARMACEUTICALS : to announce first quarter 2019 results and provide an u..
PR
04/11ACELRX PHARMACEUTICALS : Pharmaceutical's pooled safety results for sufentanil s..
PR
03/12ACELRX PHARMACEUTICALS : to Present at Oppenheimer and Co. Inc. 29th Annual Heal..
AQ
03/11ACELRX PHARMACEUTICALS : to Present at Oppenheimer & Co. Inc. 29th Annual Health..
PR
More news